82 FR 35786 - Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration Federal Register Volume 82, Issue 146 (August 1, 2017)
Substance Abuse and Mental Health Services Administration
Federal Register Volume 82, Issue 146 (August 1, 2017)
| Page Range | 35786-35788 | |
| FR Document | 2017-16131 |
[Federal Register Volume 82, Number 146 (Tuesday, August 1, 2017)] [Notices] [Pages 35786-35788] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-16131] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies AGENCY: Substance Abuse and Mental Health Services Administration, HHS. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: The Department of Health and Human Services (HHS) notifies federal agencies of the laboratories and Instrumented Initial Testing Facilities (IITF) currently certified to meet the [[Page 35787]] standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines). A notice listing all currently HHS-certified laboratories and IITFs is published in the Federal Register during the first week of each month. If any laboratory or IITF certification is suspended or revoked, the laboratory or IITF will be omitted from subsequent lists until such time as it is restored to full certification under the Mandatory Guidelines. If any laboratory or IITF has withdrawn from the HHS National Laboratory Certification Program (NLCP) during the past month, it will be listed at the end and will be omitted from the monthly listing thereafter. This notice is also available on the Internet at http://www.samhsa.gov/workplace. FOR FURTHER INFORMATION CONTACT: Giselle Hersh, Division of Workplace Programs, SAMHSA/CSAP, 5600 Fishers Lane, Room 16N03A, Rockville, Maryland 20857; 240-276-2600 (voice). SUPPLEMENTARY INFORMATION: The Department of Health and Human Services (HHS) notifies federal agencies of the laboratories and Instrumented Initial Testing Facilities (IITF) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines). The Mandatory Guidelines were first published in the Federal Register on April 11, 1988 (53 FR 11970), and subsequently revised in the Federal Register on June 9, 1994 (59 FR 29908); September 30, 1997 (62 FR 51118); April 13, 2004 (69 FR 19644); November 25, 2008 (73 FR 71858); December 10, 2008 (73 FR 75122); and on April 30, 2010 (75 FR 22809). The Mandatory Guidelines were initially developed in accordance with Executive Order 12564 and section 503 of Public Law 100-71. The ``Mandatory Guidelines for Federal Workplace Drug Testing Programs,'' as amended in the revisions listed above, requires strict standards that laboratories and IITFs must meet in order to conduct drug and specimen validity tests on urine specimens for federal agencies. To become certified, an applicant laboratory or IITF must undergo three rounds of performance testing plus an on-site inspection. To maintain that certification, a laboratory or IITF must participate in a quarterly performance testing program plus undergo periodic, on-site inspections. Laboratories and IITFs in the applicant stage of certification are not to be considered as meeting the minimum requirements described in the HHS Mandatory Guidelines. A HHS-certified laboratory or IITF must have its letter of certification from HHS/SAMHSA (formerly: HHS/NIDA), which attests that it has met minimum standards. In accordance with the Mandatory Guidelines dated November 25, 2008 (73 FR 71858), the following HHS-certified laboratories and IITFs meet the minimum standards to conduct drug and specimen validity tests on urine specimens: HHS-Certified Instrumented Initial Testing Facilities Dynacare, 6628 50th Street NW., Edmonton, AB Canada T6B 2N7, 780-784- 1190, (Formerly: Gamma-Dynacare Medical Laboratories) HHS-Certified Laboratories ACM Medical Laboratory, Inc., 160 Elmgrove Park, Rochester, NY 14624, 844-486-9226 Aegis Analytical Laboratories, Inc., 345 Hill Ave., Nashville, TN 37210, 615-255-2400, (Formerly: Aegis Sciences Corporation, Aegis Analytical Laboratories, Inc., Aegis Analytical Laboratories). Alere Toxicology Services, 1111 Newton St., Gretna, LA 70053, 504-361- 8989/800-433-3823, (Formerly: Kroll Laboratory Specialists, Inc., Laboratory Specialists, Inc.) Alere Toxicology Services, 450 Southlake Blvd., Richmond, VA 23236, 804-378-9130, (Formerly: Kroll Laboratory Specialists, Inc., Scientific Testing Laboratories, Inc.; Kroll Scientific Testing Laboratories, Inc.) Baptist Medical Center-Toxicology Laboratory, 11401 I-30, Little Rock, AR 72209-7056, 501-202-2783, (Formerly: Forensic Toxicology Laboratory Baptist Medical Center) Clinical Reference Laboratory, Inc., 8433 Quivira Road, Lenexa, KS 66215-2802, 800-445-6917 DrugScan, Inc., 200 Precision Road, Suite 200, Horsham, PA 19044, 800- 235-4890 Dynacare*, 245 Pall Mall Street, London, ONT, Canada N6A 1P4, 519-679- 1630, (Formerly: Gamma-Dynacare Medical Laboratories) ElSohly Laboratories, Inc., 5 Industrial Park Drive, Oxford, MS 38655, 662-236-2609 Laboratory Corporation of America Holdings, 7207 N. Gessner Road, Houston, TX 77040, 713-856-8288/800-800-2387 Laboratory Corporation of America Holdings, 69 First Ave., Raritan, NJ 08869, 908-526-2400/800-437-4986, (Formerly: Roche Biomedical Laboratories, Inc.) Laboratory Corporation of America Holdings, 1904 TW Alexander Drive, Research Triangle Park, NC 27709, 919-572-6900/800-833-3984, (Formerly: LabCorp Occupational Testing Services, Inc., CompuChem Laboratories, Inc.; CompuChem Laboratories, Inc., A Subsidiary of Roche Biomedical Laboratory; Roche CompuChem Laboratories, Inc., A Member of the Roche Group) Laboratory Corporation of America Holdings, 1120 Main Street, Southaven, MS 38671, 866-827-8042/800-233-6339, (Formerly: LabCorp Occupational Testing Services, Inc.; MedExpress/National Laboratory Center) LabOne, Inc. d/b/a Quest Diagnostics, 10101 Renner Blvd., Lenexa, KS 66219, 913-888-3927/800-873-8845, (Formerly: Quest Diagnostics Incorporated; LabOne, Inc.; Center for Laboratory Services, a Division of LabOne, Inc.) MedTox Laboratories, Inc., 402 W. County Road D, St. Paul, MN 55112, 651-636-7466/800-832-3244 Legacy Laboratory Services--MetroLab, 1225 NE 2nd Ave., Portland, OR 97232, 503-413-5295/800-950-5295, (Formerly: MetroLab-Legacy Laboratory Services) Minneapolis Veterans Affairs Medical Center, Forensic Toxicology Laboratory, 1 Veterans Drive, Minneapolis, MN 55417, 612-725-2088, Testing for Veterans Affairs (VA) Employees Only National Toxicology Laboratories, Inc., 1100 California Ave., Bakersfield, CA 93304, 661-322-4250/800-350-3515 One Source Toxicology Laboratory, Inc., 1213 Genoa-Red Bluff, Pasadena, TX 77504, 888-747-3774, (Formerly: University of Texas Medical Branch, Clinical Chemistry Division; UTMB Pathology-Toxicology Laboratory) Pacific Toxicology Laboratories, 9348 DeSoto Ave., Chatsworth, CA 91311, 800-328-6942, (Formerly: Centinela Hospital Airport Toxicology Laboratory) Pathology Associates Medical Laboratories, 110 West Cliff Dr., Spokane, WA 99204, 509-755-8991/800-541-7891x7 Phamatech, Inc., 15175 Innovation Drive, San Diego, CA 92128, 888-635- 5840 Quest Diagnostics Incorporated, 1777 Montreal Circle, Tucker, GA 30084, 800-729-6432, (Formerly: SmithKline Beecham Clinical Laboratories; SmithKline Bio-Science Laboratories) Quest Diagnostics Incorporated, 400 Egypt Road, Norristown, PA 19403, 610-631-4600/877-642-2216, (Formerly: SmithKline Beecham [[Page 35788]] Clinical Laboratories; SmithKline Bio-Science Laboratories) Quest Diagnostics Incorporated, 8401 Fallbrook Ave., West Hills, CA 91304, 818-737-6370, (Formerly: SmithKline Beecham Clinical Laboratories) Redwood Toxicology Laboratory, 3700 Westwind Blvd., Santa Rosa, CA 95403, 800-255-2159 STERLING Reference Laboratories, 2617 East L Street, Tacoma, Washington 98421, 800-442-0438 US Army Forensic Toxicology Drug Testing Laboratory, 2490 Wilson St., Fort George G. Meade, MD 20755-5235, 301-677-7085, Testing for Department of Defense (DoD) Employees Only --------------------------------------------------------------------------- \*\ The Standards Council of Canada (SCC) voted to end its Laboratory Accreditation Program for Substance Abuse (LAPSA) effective May 12, 1998. Laboratories certified through that program were accredited to conduct forensic urine drug testing as required by U.S. Department of Transportation (DOT) regulations. As of that date, the certification of those accredited Canadian laboratories will continue under DOT authority. The responsibility for conducting quarterly performance testing plus periodic on-site inspections of those LAPSA-accredited laboratories was transferred to the U.S. HHS, with the HHS' NLCP contractor continuing to have an active role in the performance testing and laboratory inspection processes. Other Canadian laboratories wishing to be considered for the NLCP may apply directly to the NLCP contractor just as U.S. laboratories do. Upon finding a Canadian laboratory to be qualified, HHS will recommend that DOT certify the laboratory (Federal Register, July 16, 1996) as meeting the minimum standards of the Mandatory Guidelines published in the Federal Register on November 25, 2008 (73 FR 71858). After receiving DOT certification, the laboratory will be included in the monthly list of HHS-certified laboratories and participate in the NLCP certification maintenance program. Charles LoDico, Chemist. [FR Doc. 2017-16131 Filed 7-31-17; 8:45 am] BILLING CODE 4160-20-P
![35786 Federal Register / Vol. 82, No. 146 / Tuesday, August 1, 2017 / Notices
Conference Room, 10 Center Drive, Bethesda, Time: 3:30 p.m. to 5:30 p.m. Room 10, 9000 Rockville Pike, Bethesda, MD
MD 20892. Agenda: To review and evaluate grant 20892.
Contact Person: Michael W. Krause, Ph.D., applications. Open: September 27, 2017, 8:00 a.m. to
Scientific Director, National Institute of Place: National Institutes of Health, 5601 12:30 p.m.
Diabetes and Digestive and Kidney Diseases, Fishers Lane, Rockville, MD 20892 Agenda: Call to order and report from the
National Institute of Health, Building 5, (Telephone Conference Call) Director; Discussion of future meeting dates;
Room B104, Bethesda, MD 20892–1818, (301) Contact Person: Peter R. Jackson, Ph.D., Consideration of minutes of last meeting;
402–4633, mwkrause@helix.nih.gov. Chief, AIDS Research Review Branch Reports from Task Force on Minority Aging
(Catalogue of Federal Domestic Assistance Scientific Review Program, Division of Research, Working Group on Program;
Program Nos. 93.847, Diabetes, Extramural Activities, Room # 3G20, Council Speaker; Program Highlights.
Endocrinology and Metabolic Research; National Institutes of Health/NIAID, 5601 Place: National Institutes of Health,
93.848, Digestive Diseases and Nutrition Fishers Lane, MSC 9823, Bethesda, MD Building 31, C Wing, 6th Floor, Conference
Research; 93.849, Kidney Diseases, Urology 20892–9823, (240) 669–5049, pjackson@ Room 10, 9000 Rockville Pike, Bethesda, MD
and Hematology Research, National Institutes niaid.nih.gov. 20892.
of Health, HHS) (Catalogue of Federal Domestic Assistance Contact Person: Robin Barr, Director,
Program Nos. 93.855, Allergy, Immunology, National Institute on Aging, Office of
Dated: July 26, 2017. Extramural Activities, Gateway Building,
and Transplantation Research; 93.856,
David Clary, 7201 Wisconsin Avenue, Bethesda, MD
Microbiology and Infectious Diseases
Program Analyst, Office of Federal Advisory Research, National Institutes of Health, HHS) 20814, (301) 496–9322, barrr@nia.nih.gov.
Committee Policy. Any interested person may file written
Dated: July 26, 2017. comments with the committee by forwarding
[FR Doc. 2017–16116 Filed 7–31–17; 8:45 am]
Natasha M. Copeland, the statement to the Contact Person listed on
BILLING CODE 4140–01–P
Program Analyst, Office of Federal Advisory this notice. The statement should include the
Committee Policy. name, address, telephone number and when
DEPARTMENT OF HEALTH AND [FR Doc. 2017–16115 Filed 7–31–17; 8:45 am] applicable, the business or professional
affiliation of the interested person.
HUMAN SERVICES BILLING CODE 4140–01–P
In the interest of security, NIH has
instituted stringent procedures for entrance
National Institutes of Health onto the NIH campus. All visitor vehicles,
DEPARTMENT OF HEALTH AND including taxicabs, hotel, and airport shuttles
National Institute of Allergy and HUMAN SERVICES will be inspected before being allowed on
Infectious Diseases; Notice of Closed campus. Visitors will be asked to show one
Meetings National Institutes of Health form of identification (for example, a
Pursuant to section 10(d) of the government-issued photo ID, driver’s license,
National Institute on Aging; Notice of or passport) and to state the purpose of their
Federal Advisory Committee Act, as Meeting visit.
amended (5 U.S.C. App.), notice is Information is also available on the
hereby given of the following meetings. Pursuant to section 10(d) of the Institute’s/Center’s home page:
The meetings will be closed to the Federal Advisory Committee Act, as www.nia.nih.gov/about/naca, where an
public in accordance with the amended, notice is hereby given of a agenda and any additional information for
provisions set forth in sections meeting of the National Advisory the meeting will be posted when available.
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Council on Aging. (Catalogue of Federal Domestic Assistance
as amended. The grant applications and The meeting will be open to the Program Nos. 93.866, Aging Research,
the discussions could disclose public as indicated below, with National Institutes of Health, HHS).
confidential trade secrets or commercial attendance limited to space available. Dated: July 26, 2017.
property such as patentable material, Individuals who plan to attend and
Melanie J. Pantoja,
and personal information concerning need special assistance, such as sign
language interpretation or other Program Analyst, Office of Federal Advisory
individuals associated with the grant Committee Policy.
applications, the disclosure of which reasonable accommodations, should
[FR Doc. 2017–16114 Filed 7–31–17; 8:45 am]
would constitute a clearly unwarranted notify the Contact Person listed below
in advance of the meeting. BILLING CODE 4140–01–P
invasion of personal privacy.
The meeting will be closed to the
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
public in accordance with the
provisions set forth in sections DEPARTMENT OF HEALTH AND
Emphasis Panel; NIAID Clinical Trial HUMAN SERVICES
Implementation Cooperative Agreement 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
(U01). as amended. The grant applications and Substance Abuse and Mental Health
Date: August 24, 2017. the discussions could disclose Services Administration
Time: 1:00 p.m. to 2:30 p.m. confidential trade secrets or commercial
Agenda: To review and evaluate grant property such as patentable material, Current List of HHS-Certified
applications. and personal information concerning
Place: National Institutes of Health, 5601 Laboratories and Instrumented Initial
individuals associated with the grant Testing Facilities Which Meet Minimum
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call)
applications, the disclosure of which Standards To Engage in Urine Drug
Contact Person: Jane K. Battles, Ph.D., would constitute a clearly unwarranted Testing for Federal Agencies
Scientific Review Officer, Scientific Review invasion of personal privacy.
Program, Division of Extramural Activities, AGENCY: Substance Abuse and Mental
Name of Committee: National Advisory
mstockstill on DSK30JT082PROD with NOTICES
National Institutes of Health/NIAID, 5601 Health Services Administration, HHS.
Council on Aging.
Fishers Lane, Room 3F30B, Rockville, MD Date: September 26–27, 2017. ACTION: Notice.
20852, 240–669–5029, battlesja@ Closed: September 26, 2017, 3:00 p.m. to
mail.nih.gov. 5:00 p.m.
SUMMARY: The Department of Health and
Name of Committee: National Institute of Agenda: To review and evaluate to review Human Services (HHS) notifies federal
Allergy and Infectious Diseases Special and evaluate grant applications. agencies of the laboratories and
Emphasis Panel; AIDSRRC Independent SEP. Place: National Institutes of Health, Instrumented Initial Testing Facilities
Date: August 25, 2017. Building 31, C Wing, 6th Floor, Conference (IITF) currently certified to meet the
VerDate Sep<11>2014 20:13 Jul 31, 2017 Jkt 241001 PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 E:\FR\FM\01AUN1.SGM 01AUN1](https://thefederalregister.org/doc/82_FR_35932/page/1.svg)
![35788 Federal Register / Vol. 82, No. 146 / Tuesday, August 1, 2017 / Notices
Clinical Laboratories; SmithKline Bio- Enforcement (USICE) is submitting the sponsoring the collection: Form I–133;
Science Laboratories) following information collection request U.S. Immigration and Customs
Quest Diagnostics Incorporated, 8401 for review and clearance in accordance Enforcement.
Fallbrook Ave., West Hills, CA 91304, with the Paperwork Reduction Act of (4) Affected public who will be asked
818–737–6370, (Formerly: SmithKline 1995. The information collection is or required to respond, as well as a brief
Beecham Clinical Laboratories) published in the Federal Register to abstract: Primary: Individual or
Redwood Toxicology Laboratory, 3700 obtain comments from the public and Households, Business or other non-
Westwind Blvd., Santa Rosa, CA affected agencies. This information profit. The data collected on this form
95403, 800–255–2159 collection was previously published in is used by ICE to ensure accuracy in
STERLING Reference Laboratories, 2617 the Federal Register on May 26, 2017, correspondence between ICE and the
East L Street, Tacoma, Washington Vol. 82 No. 24377 allowing for a 60 day obligor. The form serves the purpose of
98421, 800–442–0438 comment period. USICE did not receive standardizing obligor notification of any
US Army Forensic Toxicology Drug a comment in connection with the 60- changes in their address, and will
Testing Laboratory, 2490 Wilson St., day notice. The purpose of this notice facilitate communication with the
Fort George G. Meade, MD 20755– is to allow an additional 30 days for obligor.
5235, 301–677–7085, Testing for public comments, (5) An estimate of the total number of
Department of Defense (DoD) Written comments and suggestions respondents and the amount of time
Employees Only regarding items contained in this notice estimated for an average respondent to
Charles LoDico, and especially with regard to the respond: 12,000 responses at 15 minutes
Chemist. estimated public burden and associated (.25 hours) per response.
response time should be directed to the (6) An estimate of the total public
[FR Doc. 2017–16131 Filed 7–31–17; 8:45 am]
Office of Information and Regulatory burden (in hours) associated with the
BILLING CODE 4160–20–P
Affairs, Office of Management and collection: 3,000 annual burden hours.
Budget. Comments should be addressed Dated: July 26, 2017.
DEPARTMENT OF HOMELAND to the OMB Desk Officer for U.S. Scott Elmore,
SECURITY Immigration and Customs Enforcement, PRA Clearance Officer, Office of the Chief
Department of Homeland Security, and Information Officer, U.S. Immigration and
U.S. Immigration and Customs sent via electronic mail to dhsdesk Customs Enforcement, Department of
Enforcement officer@omb.eop.gov. Homeland Security.
Written comments and suggestions [FR Doc. 2017–16085 Filed 7–31–17; 8:45 am]
Agency Information Collection from the public and affected agencies BILLING CODE 9111–28–P
Activities: Extension, Without concerning the proposed collection of
Changes, of an Existing Information information should address one or more
Collection; Comment Request; OMB of the following four points: DEPARTMENT OF HOUSING AND
Control No. 1653–0042 (1) Evaluate whether the proposed
URBAN DEVELOPMENT
collection of information is necessary
AGENCY: U.S. Immigration and Customs for the proper performance of the [Docket No. FR–5997–N–39]
Enforcement, Department of Homeland functions of the agency, including
Security. whether the information will have 60-Day Notice of Proposed Information
ACTION: 30-Day Notice of Information practical utility; Collection: Implementation of the
collection for review; Form No. I–333, (2) Evaluate the accuracy of the Violence Against Women
Obligor Change of Address; OMB agencies estimate of the burden of the Reauthorization Act of 2013
Control No. 1653–0042. proposed collection of information, AGENCY: Offices of Housing, Public and
The Department of Homeland including the validity of the Indian Housing, and Community
Security, U.S. Immigration and Customs methodology and assumptions used; Planning and Development, HUD.
(3) Enhance the quality, utility, and
ACTION: Notice.
* The Standards Council of Canada (SCC) voted
clarity of the information to be
to end its Laboratory Accreditation Program for collected; and SUMMARY: HUD is seeking approval from
Substance Abuse (LAPSA) effective May 12, 1998. (4) Minimize the burden of the the Office of Management and Budget
Laboratories certified through that program were collection of information on those who
accredited to conduct forensic urine drug testing as
(OMB) for the information collection
required by U.S. Department of Transportation
are to respond, including through the described below. In accordance with the
(DOT) regulations. As of that date, the certification use of appropriate automated, Paperwork Reduction Act, HUD is
of those accredited Canadian laboratories will electronic, mechanical, or other requesting comment from all interested
continue under DOT authority. The responsibility technological collection techniques or
for conducting quarterly performance testing plus parties on the proposed collection of
periodic on-site inspections of those LAPSA- other forms of information technology, information. The purpose of this notice
accredited laboratories was transferred to the U.S. e.g., permitting electronic submission of is to allow for 60 days of public
HHS, with the HHS’ NLCP contractor continuing to responses. comment.
have an active role in the performance testing and
laboratory inspection processes. Other Canadian Overview of This Information DATES: Comments Due Date: October 2,
laboratories wishing to be considered for the NLCP Collection
may apply directly to the NLCP contractor just as
2017.
U.S. laboratories do. (1) Type of Information Collection: ADDRESSES: Interested persons are
Upon finding a Canadian laboratory to be Extension, without changes, of a invited to submit comments regarding
mstockstill on DSK30JT082PROD with NOTICES
qualified, HHS will recommend that DOT certify this proposal. Comments should refer to
the laboratory (Federal Register, July 16, 1996) as
currently approved information
meeting the minimum standards of the Mandatory collection. the proposal by name and/or OMB
Guidelines published in the Federal Register on (2) Title of the Form/Collection: Control Number and should be sent to:
November 25, 2008 (73 FR 71858). After receiving Obligor Change of Address. Colette Pollard, Reports Management
DOT certification, the laboratory will be included
in the monthly list of HHS-certified laboratories and
(3) Agency form number, if any, and Officer, QDAM, Department of Housing
participate in the NLCP certification maintenance the applicable component of the and Urban Development, 451 7th Street
program. Department of Homeland Security SW., Room 4176, Washington, DC
VerDate Sep<11>2014 20:13 Jul 31, 2017 Jkt 241001 PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 E:\FR\FM\01AUN1.SGM 01AUN1](https://thefederalregister.org/doc/82_FR_35932/page/3.svg)
Document Created: 2018-10-24 11:43:34
Document Modified: 2018-10-24 11:43:34
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice. | |
| Contact | Giselle Hersh, Division of Workplace Programs, SAMHSA/CSAP, 5600 Fishers Lane, Room 16N03A, Rockville, Maryland 20857; 240-276-2600 (voice). | |
| FR Citation | 82 FR 35786 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR